Aruna Subramanian

Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »

4.8/5

10 Patient Ratings »

8 Patient Reviews »

Biography

Clinical Focus: Chief, Immunocompromised Host Infectious Diseases

This includes the prevention, diagnosis and treatment of Infections in patients who are immunosuppressed because of:

Solid Organ Transplantation (Kidney, Pancreas, Liver, Heart, Lung, Small Bowel)
Bone Marrow (Hematopoeitic Cell) Transplants
Hematologic Malignancies
Chemotherapy for Solid Tumors
HIV who receive Chemotherapy,Solid Organ or Bone Marrow Transplants
Immunomodulators for Auto-Immune Diseases

View Full Biography »

Professional Summary

Professional Education

Board Certification: American Board of Internal Medicine, Infectious Disease (1999)
Fellowship: Johns Hopkins University Division of Infectious Diseases (2000) MD
Medical Education: University of Michigan Medical School (1994) MI

Residency: University Hospitals of Cleveland - Case Western Reserve (1997) OH

Board Certification: American Board of Internal Medicine, Internal Medicine (1997)

Fellowship, Johns Hopkins University School of Medicine, Infectious Diseases (2001)

Residency, University Hospitals of Cleveland (Case Western Reserve), Internal Medicine (1997)

Medical School, University of Michigan, Medicine (1994)

Honors & Awards

Associate Editor, Transplant Infectious Diseases Journal (2004-2016)
Award for Outstanding Research, Case Western Reserve University (UHC) (1997)
Fellow of AST (FAST), American Society of Transplantation (2018)

Fellow of IDSA (FIDSA), Infectious Diseases Society of America (2014)

Sidney Finegold Outstanding Reviewer Award, Clinical Infectious Diseases Journal (2009)

William Dodd Robinson Award for Excellence in Internal Medicine, University of Michigan (1994)

Administrative Appointments

Chief, Immunocompromised Host ID Service, Stanford University, Division of Infectious Diseases (2013 - Present)
Co-Director, Transplant and Oncology ID Service, Johns Hopkins University School of Medicine (2003 - 2011)
Co-PI, AIDS Clinical Trials Unit, Johns Hopkins University School of Medicine (2001 - 2003)

Publications

Mycobacterium tuberculosis Infections in Solid Organ Transplantation
Subramanian, A. K., & Morris, M. I. (2013). Mycobacterium tuberculosis Infections in Solid Organ Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 68–76.
Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients
Neofytos, D., Kobayashi, K., Alonso, C. D., Cady-Reh, J., Lepley, D., Harris, M., … Marr, K. (2013). Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients. TRANSPLANT INFECTIOUS DISEASE, 15(2), 134–141.
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Stock, P. G., Barin, B., Murphy, B., Hanto, D., Diego, J. M., Light, J., … Roland, M. E. (2010). Outcomes of Kidney Transplantation in HIV-Infected Recipients. NEW ENGLAND JOURNAL OF MEDICINE, 363(21), 2004–14.

Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group
Avery, R., CLAUSS, H., Danziger-Isakov, L., Davis, J., Doucette, K., van Duin, D., … Subramanian, A. (2010). Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. TRANSPLANT INFECTIOUS DISEASE, 12(3), 190–194.

MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates
Subramanian, A., Sulkowski, M., Barin, B., Stablein, D., Curry, M., Nissen, N., … Ragni, M. (2010). MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. GASTROENTEROLOGY, 138(1), 159–64.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
Terrault, N. A., Roland, M. E., Schiano, T., Dove, L., Wong, M. T., Poordad, F., … Stock, P. G. (2012). Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. LIVER TRANSPLANTATION, 18(6), 716–726.

Donor-derived organ transplant transmission of coccidioidomycosis
Dierberg, K. L., Marr, K. A., Subramanian, A., Nace, H., Desai, N., Locke, J. E., … Neofytos, D. (2012). Donor-derived organ transplant transmission of coccidioidomycosis. TRANSPLANT INFECTIOUS DISEASE, 14(3), 300–304.

Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft
Bagnasco, S. M., Subramanian, A. K., & Desai, N. M. (2012). Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft. TRANSPLANT INFECTIOUS DISEASE, 14(3), 288–291.

Tuberculosis in solid organ transplant candidates and recipients: current and future challenges.
Subramanian, A. K. (2014). Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Current Opinion in Infectious Diseases, 27(4), 316–21.

False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae
Gajurel, K., & Subramanian, A. K. (2016). False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 84(4), 315–17.

False-positive hepatitis C virus serology after placement of a ventricular assistance device
Durand, C. M., Marr, K. A., OSTRANDER, D., Subramanian, A., Valsamakis, A., Cox, A., & Neofytos, D. (2016). False-positive hepatitis C virus serology after placement of a ventricular assistance device. TRANSPLANT INFECTIOUS DISEASE, 18(1), 146–49.

Cutaneous zygomycosis (mucormycosis)
Carpenter, C. F., & Subramanian, A. K. (1999). Cutaneous zygomycosis (mucormycosis). NEW ENGLAND JOURNAL OF MEDICINE, 341(25), 1891–91.

Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss
Locke, J. E., Montgomery, R. A., Warren, D. S., Subramanian, A., & Segev, D. L. (2009). Renal Transplant in HIV-Positive Patients Long-term Outcomes and Risk Factors for Graft Loss. ARCHIVES OF SURGERY, 144(1), 83–86.

Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation
Kucirka, L. M., Ros, L., Subramanian, A. K., Montgomery, R. A., & Segev, D. L. (2011). Provider Response to a Rare but Highly Publicized Transmission of HIV Through Solid Organ Transplantation. ARCHIVES OF SURGERY, 146(1), 41–45.

The high-risk donor: viral infections in solid organ transplantation
Singer, A. L., Kucirka, L. M., Namuyinga, R., Hanrahan, C., Subramanian, A. K., & Segev, D. L. (2008). The high-risk donor: viral infections in solid organ transplantation. CURRENT OPINION IN ORGAN TRANSPLANTATION, 13(4), 400–404.

Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation
Subramanian, A. K., Quinn, T. C., Kickler, T. S., Kasper, E. K., & Tucker, P. C. (2002). Correlation of Chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation. TRANSPLANTATION, 73(5), 761–64.

Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation
Hoffmann, C. J., Subramanian, A. K., Cameron, A. M., & Engels, E. A. (2008). Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. TRANSPLANTATION, 86(6), 784–90.

Nontuberculous Mycobacteria in Solid Organ Transplant Recipients
Dorman, S., & Subramanian, A. (2009). Nontuberculous Mycobacteria in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S63–S69.

Antimicrobial prophylaxis regimens following transplantation
Subramanian, A. K. (2011). Antimicrobial prophylaxis regimens following transplantation. CURRENT OPINION IN INFECTIOUS DISEASES, 24(4), 344–49.

Mycobacterium tuberculosis in Solid Organ Transplant Recipients
Subramanian, A., & Dorman, S. (2009). Mycobacterium tuberculosis in Solid Organ Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 9, S57–S62.

Actinomucor elegans as an Emerging Cause of Mucormycosis
Mahmud, A., Lee, R., Munfus-McCray, D., Kwiatkowski, N., Subramanian, A., Neofytos, D., … Zhang, S. X. (2012). Actinomucor elegans as an Emerging Cause of Mucormycosis. JOURNAL OF CLINICAL MICROBIOLOGY, 50(3), 1092–95.

Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis).
Carpenter, C. F., & Subramanian, A. K. (1999). Images in clinical medicine. Cutaneous zygomycosis (Mucormycosis). New England Journal of Medicine, 341(25), 1891-?

West Nile virus encephalitis in a kidney transplant recipient
Shepherd, J. C., Subramanian, A., Montgomery, R. A., Samaniego, M. D., Gong, G., Bergmann, A., … Dropulic, L. (2004). West Nile virus encephalitis in a kidney transplant recipient. AMERICAN JOURNAL OF TRANSPLANTATION, 4(5), 830–33.

Should a prisoner be placed on the organ transplant waiting list?
Cameron, A. M., Subramanian, A. K., Sulkowski, M. S., Thomas, D. L., & Nelson, K. E. (2008). Should a prisoner be placed on the organ transplant waiting list? The Virtual Mentor : VM, 10(2), 88–91.

Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation
Balagopal, A., Mills, L., Shah, A., & Subramanian, A. (2009). Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. TRANSPLANT INFECTIOUS DISEASE, 11(2), 149–54.

Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients.
Epstein, D. J., Benamu, E., & Subramanian, A. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates
Tien, V., Robilotti, E., Callister, D., Subramanian, A., Lutchman, G., & Ho, D. Y. (2015). Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates. CLINICAL INFECTIOUS DISEASES, 61(10), 1631–U154.

Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors
Santoro-Lopes, G., Subramanian, A. K., Molina, I., Maria Aguado, J., Rabagliatti, R., & Len, O. (2018). Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. TRANSPLANTATION, 102(2), S60–S65.

Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients.
Epstein, D. J., & Subramanian, A. K. (2018). Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America, 32(3), 703–18.

Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient.
Tan, S. K., Cheng, X. S., Kao, C.-S., Weber, J., Pinsky, B. A., Gill, H. S., … Tan, J. C. (2018). Native Kidney Cytomegalovirus Nephritis and Cytomegalovirus Prostatitis in a Kidney Transplant Recipient. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e12998.

Infections in Transplant and Oncology Patients Preface
Marr, K. A., & Subramanian, A. K. (2010). Infections in Transplant and Oncology Patients Preface. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 24(2), XIII-XV.

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.
Roland, M. E., Barin, B., Huprikar, S., Murphy, B., Hanto, D. W., Blumberg, E., … Stock, P. G. (2016). Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (London, England), 30(3), 435–44.

Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors.
Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2018). Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation.
Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis Infections in Solid Organ Transplantation: Guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clinical Transplantation, e13513.

Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients.
Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. The Journal of Infectious Diseases.

Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption.
Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA Dermatology.

Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients
Epstein, D. J., Benamu, E., & Subramanian, A. K. (2018). Use of Alternative Agents for Prevention of Opportunistic Infections in Heart and Lung Transplant Recipients. CLINICAL INFECTIOUS DISEASES, 67(10), 1637–39.

Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature.
Multani, A., Subramanian, A. K., & Liu, A. Y. (2019). Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: case report and review of the literature. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13118.

Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors
Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2019). Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors. AMERICAN JOURNAL OF TRANSPLANTATION, 19(5), 1380–87.

Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat.
Aronson, J. R., Rezvani, A. R., & Subramanian, A. (2019). Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients
Tan, S. K., Huang, C. H., Sahoo, M. K., Weber, J., Kurzer, J., Stedman, M. R., … Pinsky, B. A. (2019). Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients. JOURNAL OF INFECTIOUS DISEASES, 220(3), 370–76.

Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption
Hirotsu, K., Dang, T. M., Li, S., Neal, J. W., Pugliese, S., Subramanian, A., & Kwong, B. Y. (2019). Association of Antibiotic Resistance With Antibiotic Use for Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption. JAMA DERMATOLOGY, 155(7), 848–50.

Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation
Subramanian, A. K., & Theodoropoulos, N. M. (2019). Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. CLINICAL TRANSPLANTATION, 33(9).

A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States
Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A., Bennett, J., … Powderly, W. (2020). A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States. CLINICAL INFECTIOUS DISEASES, 70(2), 252–61.

Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Webb, B. J., Subramanian, A., Lopansri, B., Goodman, B., Jones, P. B., Ferraro, J., … Brown, S. M. (2020). Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection. Antimicrobial Agents and Chemotherapy.

Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020
Ferguson, J., Rosser, J., Quintero, O., Scott, J., Subramanian, A., Gumma, M., … Kappagoda, S. (2020). Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, northern California, USA, March–April 2020. Emerging Infectious Diseases.

Infections Related to Biologics.
Ho, D. Y., & Subramanian, A. K. (2020). Infections Related to Biologics. Infectious Disease Clinics of North America, 34(2), xiii-xvi.

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Goldman, J. D., Lye, D. C., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., … Subramanian, A. (2020). Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. The New England Journal of Medicine.

A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., … Blish, C. A. (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nature Medicine.

Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review.
Puing, A. G., Couture-Cossette, A., Wang, A. X., Zygourakis, C. C., Cheng, X., Stevens, B. A., … Subramanian, A. (2020). Simultaneous Coccidioidomycosis and Phaeohyphomycosis in a Kidney Transplant Recipient: A Case Report and Literature Review. Transplant Infectious Disease : an Official Journal of the Transplantation Society, e13365.

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J. A., Asuni, A., … Rogers, A. J. (2020). Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight.

Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease.
Igbinosa, I., Miller, S., Bianco, K., Nelson, J., Kappagoda, S., Blackburn, B. G., … Aziz, N. (2020). Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease. American Journal of Obstetrics and Gynecology.

Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients.
Avery, R. K., Motter, J. D., Jackson, K. R., Montgomery, R. A., Massie, A. B., Kraus, E. S., … Garonzik, J. M. (2020). Quantifying Infection Risks in Incompatible Living Donor Kidney Transplant Recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS
Goldman, J. D., Lye, D. C. B., Hui, D. S.-C., Marks, K., Bruno, R., Montejano, R., … Subramanian, A. (2020). IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS. HEPATOLOGY, 72, 279A.

A single-cell atlas of the peripheral immune response to severe COVID-19.
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., … Blish, C. A. (2020). A single-cell atlas of the peripheral immune response to severe COVID-19. MedRxiv : the Preprint Server for Health Sciences.

Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal PCR Panel for Non-Invasive Diagnosis of Fungal Infection.
Senchyna, F., Hogan, C. A., Murugesan, K., Moreno, A., Ho, D. Y., Subramanian, A., … Banaei, N. (2021). Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal PCR Panel for Non-Invasive Diagnosis of Fungal Infection. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic.
Jacobson, K. B., Rao, M., Bonilla, H., Subramanian, A., Hack, I., Madrigal, M., … Grant, P. (2021). Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples
Verma, R., Kim, E., Martinez, G., Jagannathan, P., Rustagi, A., Parsonnet, J., … Andrews, J. (2021). SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples. Open Forum Infectious Diseases.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Practice Locations

Infectious Disease Clinic in Palo Alto Palo Alto, CA

Palo Alto, CA

Infectious Disease Clinic in Palo Alto

211 Quarry Road, 2nd Floor, Suite 202

Palo Alto , CA 94304

(650) 736-5200

More Clinic Information »

Heart Transplant Program Stanford, CA

Stanford, CA

Heart Transplant Program

300 Pasteur Drive , 2nd Floor, Room A21

Stanford , CA 94305

(650) 723-5468

More Clinic Information »

Post-Acute COVID-19 Syndrome (PACS) Clinic Atherton, CA

Atherton, CA

Post-Acute COVID-19 Syndrome (PACS) Clinic

3351 El Camino Real, Suite 225

Atherton , CA 94027

(650) 736-5200

More Clinic Information »

Patient Ratings

(10 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.8/5

Friendliness

4.9/5

Explanations

4.8/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

4.7/5

Clear Communication

4.7/5

Time Spent

4.8/5

Recommend to others

4.6/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(8 reviews)

Dr. Subramanian showed care and extreme concern for wound and possible infection.

May 2020

•

Verified SHC Patient

Dr. Subramanian was very helpful. Looked at my records before she came in and addressed all concerns. Very professional and gave me confidence.

Apr 2017

•

Verified SHC Patient

The doctor was exceptional in all phases.

Aug 2016

•

Verified SHC Patient

Dr. Subramarian always impresses me with her kind & caring manner. She always spends all the time I need answering all my questions in detail (I'm detail oriented) & asks if I agree with her recommendation. Great doctor!

May 2016

•

Verified SHC Patient

Top of the line people.

Feb 2016

•

Verified SHC Patient

Very good.

Dec 2015

•

Verified SHC Patient

Dr. Subramanian is so caring, so knowledgeable and makes me always feel better. A very sweet & kind doctor and person.

Feb 2015

•

Verified SHC Patient

First provider after several that is doing something to resolve my issue!

Aug 2014

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.

Send referrals online
View referral status
Access medical records

Learn More About PRISM » LOG INTO PRISM